Cargando…
Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside
Autosomal dominant polycystic kidney disease (ADPKD) is the most common life-threatening hereditary disease in the USA resulting in chronic kidney disease and the need for dialysis and transplantation. Approximately 85% of cases of ADPKD are caused by a mutation in the Pkd1 gene that encodes polycys...
Autores principales: | Kim, Hyun-Jung, Edelstein, Charles L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716095/ https://www.ncbi.nlm.nih.gov/pubmed/26894018 http://dx.doi.org/10.1016/j.krcp.2012.07.002 |
Ejemplares similares
-
Cystic Diseases of the Kidneys: From Bench to Bedside
por: Raina, Rupesh, et al.
Publicado: (2023) -
Sarcopenia in chronic kidney disease: from bench to bedside
por: Kim, Da Woon, et al.
Publicado: (2023) -
Current Management of Polycystic Ovary Syndrome: From Bench to Bedside
por: Laganà, Antonio Simone, et al.
Publicado: (2018) -
Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside
por: Zeber-Lubecka, Natalia, et al.
Publicado: (2023) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)